- Investing Ideas
- Nigerian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Nigerian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
2
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
2 companies
Fidson Healthcare
Market Cap: ₦242.9b
Manufactures and distributes pharmaceutical products in Nigeria.
FIDSON
₦101.20
7D
0%
1Y
117.6%
May & Baker Nigeria
Market Cap: ₦65.6b
May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.
MAYBAKER
₦38.00
7D
-5.0%
1Y
104.9%